FIS1 and juvenile Huntington disease: Also, treatment with P110, which inhibits the DRP1/FIS1 interaction, improves mitochondrial homeostasis in cardiomyocytes and promotes the removal of damaged mitochondria in Huntington’s disease models (Joshi et al., 2019).